Search hospitals
>
Oregon
>
Portland
Oregon Health and Science University
Claim this profile
Portland, Oregon 97239
Global Leader in Cancer
Global Leader in Solid Tumors
Conducts research for Leukemia
Conducts research for Lung Cancer
Conducts research for Lymphoma
2374 reported clinical trials
191 medical researchers
Summary
Oregon Health and Science University is a medical facility located in Portland, Oregon. This center is recognized for care of Cancer, Solid Tumors, Leukemia, Lung Cancer, Lymphoma and other specialties. Oregon Health and Science University is involved with conducting 2,374 clinical trials across 2,395 conditions. There are 191 research doctors associated with this hospital, such as Katrina Winsnes, Christopher W. Ryan, Bill Chang, and Matthew Taylor, MD.
Area of expertise
Cancer
Oregon Health and Science University has run 207 trials for Cancer. Some of their research focus areas include:
Solid Tumors
Oregon Health and Science University has run 116 trials for Solid Tumors. Some of their research focus areas include:
Top PIs
Katrina Winsnes
Oregon Health and Science University
8 years of reported clinical research
Christopher W. Ryan
Oregon Health and Science University
3 years of reported clinical research
Bill Chang
Oregon Health and Science University
9 years of reported clinical research
Matthew Taylor, MD
Providence Portland Medical Center
5 years of reported clinical research
Clinical Trials running at Oregon Health and Science University
Ovarian Cancer
Cancer
Multiple Myeloma
Atopic Dermatitis
Pancreatic Cancer
Brain Tumor
Cystic Fibrosis
Carcinoid Tumor
Chronic Myeloid Leukemia
Pneumonia
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting
2 awards
Phase 3
Olaparib +/- Bevacizumab
for Ovarian Cancer
This phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer. Olaparib is a polyadenosine 5'-diphosphoribose polymerase (PARP) enzyme inhibitor and may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving olaparib for one year with or without bevacizumab may be effective in treating patients with BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer, when compared to two years of olaparib.
Recruiting
2 awards
Phase 3
4 criteria
Rina-S
for Ovarian Cancer
This phase 3 study will be conducted in different countries all over the world. The purpose of this study is to compare how well Rina-S works against platinum-resistant ovarian cancer compared to chemotherapy drugs that are already approved and used for platinum-resistant ovarian cancer. Treatment in this study could be Rina-S or it could be 1 of 4 indicated chemotherapy agents that are considered standard medical care. There is an equal (50:50) chance of getting Rina-S or an approved chemotherapy agent as treatment in this study. No one will know what treatment they are assigned to until the first dose. All participants will receive active drug; no one will be given placebo.
Recruiting
2 awards
Phase 3
4 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Oregon Health and Science University?
Oregon Health and Science University is a medical facility located in Portland, Oregon. This center is recognized for care of Cancer, Solid Tumors, Leukemia, Lung Cancer, Lymphoma and other specialties. Oregon Health and Science University is involved with conducting 2,374 clinical trials across 2,395 conditions. There are 191 research doctors associated with this hospital, such as Katrina Winsnes, Christopher W. Ryan, Bill Chang, and Matthew Taylor, MD.
Where is Oregon Health and Science University located?
The Oregon Health and Science University (OHSU) Hospital is situated in southwest Portland, OR, mainly on the Marquam Hill Campus. Its primary facility, OHSU Hospital, is located at 3181 SW Sam Jackson Park Rd, Portland, OR 97239.
Who should I call to ask about financial aid or insurance network?
**Oregon Health and Science University (OHSU) Hospital Financial and Insurance Assistance Contacts:** - **Financial Assistance:** - Phone: 503-494-8551 (Weekdays 8 a.m. to 4:30 p.m.) - **Payment Plans:** - OHSU and Hillsboro Medical Center: 866-617-6855 - Adventist Health Portland: 503-261-6095 - **General Inquiries:** - Phone: 503-494-8551 or 888-311-1283 - **Insurance-Related Matters:** - Oregon Health Plan (Medicaid & CHIP): 800-699-9075 - Email: [OHP Contact Email] - Phone: 1-800-273-0557 - Mail: PO Box 14015, Salem, OR 97309
What insurance does Oregon Health and Science University accept?
Oregon Health and Science University (OHSU) accepts various insurance plans, including original Medicare. For specific coverage limitations, contact the Patient Estimate Team at 503-494-3508 or use the online price estimate tool. OHSU has arrangements with networks like PacificSource for student health insurance and offers resources for navigating insurance appeals and denials.
What awards or recognition has Oregon Health and Science University received?
Oregon Health and Science University (OHSU) in Portland, Oregon, is renowned for its research and care, earning the title of "Special Focus - Research Institution" by the Carnegie Classification. It excels in cancer research, cardiovascular medicine, ophthalmology, and pediatric care. OHSU also benefits from substantial research funding, with awards and grants provided by the Medical Research Foundation.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.